Karuna Therapeutics (KRTX) EBITDA

Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.149
52W Range: $158.375-329.99
Website: Karuna Therapeutics

What is Karuna Therapeutics's EBITDA?

  • Karuna Therapeutics's annual EBITDA is $-493.08M.
  • Karuna Therapeutics's quarterly EBITDA is $-129.14M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess Karuna Therapeutics's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: -75393.88%
    • Quarterly: 0.00%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: -70.22%
    • Quarterly: 5.20%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: -2668.49%
    • Quarterly: 0.00%

These metrics provide insights into Karuna Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$-493.08M

Quarterly EBITDA

$-129.14M

Karuna Therapeutics Historical EBITDA
EBITDA (Annual)
EBITDA (Quarterly)
$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00M-$300.00M-$300.00M-$400.00M-$400.00M-$500.00M-$500.00MEBITDA201820182019201920202020202120212022202220232023
Historical EBITDA Ratio (Annual)
0.00%0.00%-20000.00%-20000.00%-40000.00%-40000.00%-60000.00%-60000.00%-80000.00%-80000.00%EBITDA Ratio20182018201920192020202020212021202220222023202320242024
Historical EBITDA Ratio (Quarterly)
0.00%0.00%-20000.00%-20000.00%-40000.00%-40000.00%-60000.00%-60000.00%-80000.00%-80000.00%-100000.00%-100000.00%EBITDA Ratio201920192020202020212021202220222023202320242024

Karuna Therapeutics Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2023 $-493.08M -70.22% -75393.88% -2668.49%
2022 $-289.68M -102.36% -2723.29% -603.20%
2021 $-143.15M -108.95% -387.27% 0.00%
2020 $-68.51M -59.78% 0.00% 0.00%
2019 $-42.88M -196.13% 0.00% 0.00%
2018 $-14.48M -201.33% 0.00% 0.00%
2017 $-4.80M 0.00% 0.00% 0.00%

Related Metrics

Explore detailed financial metrics and analysis for KRTX.